Eyleen A. De Poel

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing.

High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing.

Journal: ERJ open research

Published: September 28, 2022

FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes.

FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: September 13, 2022

A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases.

A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases.

Journal: Science translational medicine

Published: March 30, 2022

Functional Restoration of CFTR Nonsense Mutations in Intestinal Organoids.

Functional Restoration of CFTR Nonsense Mutations in Intestinal Organoids.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: April 21, 2021

CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy.

CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy.

Journal: Frontiers in molecular biosciences

Published: April 21, 2021

Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression.

Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression.

Journal: The European respiratory journal

Published: February 17, 2021

Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.

Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.

Journal: Life science alliance

Published: October 19, 2020

Intestinal organoids for Cystic Fibrosis research.

Intestinal organoids for Cystic Fibrosis research.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: August 08, 2019

A 'catch-and-release' receptor for the cholera toxin.

A 'catch-and-release' receptor for the cholera toxin.

Journal: Faraday discussions

Published: July 18, 2019

CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank.

CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank.

Journal: Cell stem cell

Published: July 02, 2019

Strong Inhibition of Cholera Toxin B Subunit by Affordable, Polymer-Based Multivalent Inhibitors.

Strong Inhibition of Cholera Toxin B Subunit by Affordable, Polymer-Based Multivalent Inhibitors.

Journal: Bioconjugate chemistry

Published: January 11, 2019

R560S: A class II CFTR mutation that is not rescued by current modulators.

R560S: A class II CFTR mutation that is not rescued by current modulators.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: January 14, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026